Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor and G-CSF with MEC for Relapsed/Refractory AML
NCT00906945Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in acute myeloid leukemia (AML), sponsored by Washington University School of Medicine. Started Feb 2011; status: completed.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00906945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906945.